ADMA Biologics (ADMA) Superinvestor holders
14 of the superinvestors we track hold ADMA Biologics (ADMA) in their latest 13F filings, $147M in total.
Summary
The largest holder is David Shaw (D. E. Shaw & Co.), with $44M, 0.0% of the portfolio.
In their latest quarter: 4 opened a new position, 4 added, 5 trimmed.
Who holds it
Each investor's latest 13F filing, largest stake first. What a 13F shows.
| Investor | Last change | Shares | Value | % of portfolio | Filed for |
|---|---|---|---|---|---|
| David Shaw D. E. Shaw & Co. |
Added | 5,274,597 | $44M | 0.0% | Q2 2026 |
| Stanley Druckenmiller Duquesne Family Office |
Added | 2,784,110 | $23M | 0.5% | Q2 2026 |
| Wilmot Harkey Nantahala Capital Management |
New position | 2,359,993 | $20M | 1.2% | Q2 2026 |
| Two Sigma Two Sigma Investments |
Trimmed | 2,019,887 | $17M | 0.0% | Q2 2026 |
| Terry Smith Fundsmith LLP |
Held | 1,649,493 | $14M | 0.1% | Q2 2026 |
| Cliff Asness AQR Capital Management |
Added | 1,525,581 | $13M | 0.0% | Q2 2026 |
| Jim Simons Renaissance Technologies |
Trimmed | 652,530 | $5M | 0.0% | Q2 2026 |
| Steve Cohen Point72 Asset Management |
Trimmed | 413,935 | $3M | 0.0% | Q2 2026 |
| Ray Dalio Bridgewater Associates |
Trimmed | 401,059 | $3M | 0.0% | Q2 2026 |
| Paul Marshall Marshall Wace |
New position | 307,254 | $3M | 0.0% | Q2 2026 |
| Joel Greenblatt Gotham Asset Management |
New position | 73,829 | $617,949 | 0.0% | Q2 2026 |
| Alan Howard Brevan Howard |
Added | 68,896 | $576,660 | 0.0% | Q2 2026 |
| Ensign Peak Ensign Peak Advisors |
Trimmed | 64,207 | $537,413 | 0.0% | Q2 2026 |
| Man Group Man Group plc |
New position | 22,053 | $184,584 | 0.0% | Q2 2026 |
Holders by quarter
| Quarter | Superinvestors holding it |
|---|---|
| Q2 2026 | 14 |
| Q1 2026 | 15 |
| Q4 2025 | 16 |
| Q3 2025 | 13 |
| Q2 2025 | 12 |
| Q1 2025 | 13 |
| Q4 2024 | 14 |
| Q3 2024 | 16 |
Questions about ADMA Biologics
Which superinvestors own ADMA Biologics?
14 of the superinvestors we track hold ADMA Biologics (ADMA) in their latest 13F filings, $147M in total. David Shaw, Stanley Druckenmiller, Wilmot Harkey, Two Sigma, Terry Smith, Cliff Asness.
Who is the largest superinvestor holder of ADMA?
The largest holder is David Shaw (D. E. Shaw & Co.), with $44M, 0.0% of the portfolio.
From ADMA Biologics's annual reports filed with the SEC (XBRL data), standardised by Investingly. Information only, not investment advice.